home / stock / rp:cc / rp:cc news
Canadian Investment Regulatory Organization Trading Halt - RP Canada NewsWire VANCOUVER, BC , March 15, 2024 /CNW/ - The following issues have been halted by CIRO Company: RepliCel Life Sciences Inc. TSX-Venture Symbol: RP All Issues: Yes Reason: Pend...
TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC , Jan. 4, 2023 /CNW/ - TSX VENTURE COMPANIES ELEVATION GOLD MINING CORPORATION ("ELVT.WT ") BULLETIN TYPE: Warrant Expiry-Delist BULLETIN DA...
New DermaPrecise™ patent application and patents granted for tendinopathy and skin rejuvenation technologies in key markets VANCOUVER, BC / ACCESSWIRE / August 4, 2022 / RepliCel Life Sciences Inc. (OTCPK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developi...
Independent Testing Performed by Innovacell Demonstrates the DermaPrecise ™ Control Leads to Unparalleled Post-Injection Cell Survival and Viability Consistency VANCOUVER, BC / ACCESSWIRE / August 2, 2022 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliC...
After over a year of pandemic-related delays, representatives of Japan's PMDA, attended at the Company's contract manufacturing facility, Innovacell, to review the manufacturing of RepliCel's NBDS cell therapy products VANCOUVER, BC / ACCESSWIRE / July 28, 2022 / RepliCel Life Sciences ...
This press release replaces the press release disseminated July 26, 2022 at 06:00 EDT. The press release contained the wrong image - one intended for a future press release. The corrected press release with the proper image is below: VANCOUVER, BC / ACCESSWIRE / July 26, 2022 / RepliCel...
Independent dermatology research experts at Monasterium Laboratory GmbH tested, analyzed and validated various injection parameters using donated human tissue VANCOUVER, BC / ACCESSWIRE / July 26, 2022 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the ...
News, Short Squeeze, Breakout and More Instantly...
Replicel Life Sciences Inc. Company Name:
RP:CC Stock Symbol:
TSXVC Market:
Replicel Life Sciences Inc. Website:
Canadian Investment Regulatory Organization Trading Halt - RP Canada NewsWire VANCOUVER, BC , March 15, 2024 /CNW/ - The following issues have been halted by CIRO Company: RepliCel Life Sciences Inc. TSX-Venture Symbol: RP All Issues: Yes Reason: Pend...
TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC , Jan. 4, 2023 /CNW/ - TSX VENTURE COMPANIES ELEVATION GOLD MINING CORPORATION ("ELVT.WT ") BULLETIN TYPE: Warrant Expiry-Delist BULLETIN DA...
New DermaPrecise™ patent application and patents granted for tendinopathy and skin rejuvenation technologies in key markets VANCOUVER, BC / ACCESSWIRE / August 4, 2022 / RepliCel Life Sciences Inc. (OTCPK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developi...